Lorlatinib: An additional option for ALK-positive non-small cell lung cancer?

Alice Mogenet, Pascale Tomasini, Laurent Greillier, Fabrice Barlesi

Research output: Contribution to journalComment/debate

4 Citations (Scopus)
Original languageEnglish
Pages (from-to)S383-S386
JournalTranslational Lung Cancer Research
Volume8
DOIs
Publication statusPublished - 1 Dec 2019
Externally publishedYes

Cite this